当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:134.00亿  总市值:134.20亿
流通股本:8.98亿   总股本:8.99亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金4,748,137,526.483,987,430,446.182,782,970,629.41,637,532,658.01
收到的税费返还335,716,954.95264,734,524.04181,964,997.3891,711,309.9
收到其他与经营活动有关的现金321,370,293.49315,558,373.84258,020,691.66369,462,944.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,405,224,774.924,567,723,344.063,222,956,318.442,098,706,912.05
购买商品、接受劳务支付的现金2,485,962,358.632,262,137,479.641,610,853,493.81910,380,469.95
支付给职工以及为职工支付的现金833,281,659.96651,689,360.17458,158,643.09274,361,368.83
支付的各项税费308,392,029.23247,696,262.54152,958,811.6969,902,108.9
支付其他与经营活动有关的现金417,264,796.71260,932,386.47282,119,284.43387,178,902.18
经营活动现金流出的平衡项目0000
经营活动现金流出小计4,044,900,844.533,422,455,488.822,504,090,233.021,641,822,849.86
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,360,323,930.391,145,267,855.24718,866,085.42456,884,062.19
二、投资活动产生的现金流量:
处置固定资产、无形资产和其他长期资产收回的现金净额3,995,360.561,035,611.9581,770.5581,770.5
收到的其他与投资活动有关的现金25,749,511.03---
投资活动现金流入的平衡项目0000
投资活动现金流入小计29,744,871.591,035,611.9581,770.5581,770.5
购建固定资产、无形资产和其他长期资产支付的现金929,441,884.64611,692,400.27405,394,923211,620,984.12
投资支付的现金41,266,36033,863,250.622,945,078.3614,350,917.83
取得子公司及其他营业单位支付的现金113,340,026.18106,835,429.69106,835,429.69106,835,429.69
支付其他与投资活动有关的现金2,500,000---
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,086,548,270.82752,391,080.56535,175,431.05332,807,331.64
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,056,803,399.23-751,355,468.66-534,593,660.55-332,225,561.14
三、筹资活动产生的现金流量:
吸收投资收到的现金2,490,999,971.422,490,999,971.422,490,999,971.422,490,999,971.42
取得借款收到的现金2,112,560,0001,662,560,0001,161,000,000684,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计4,603,559,971.424,153,559,971.423,651,999,971.423,174,999,971.42
偿还债务支付的现金2,050,000,0001,009,000,000490,000,000259,000,000
分配股利、利润或偿付利息支付的现金386,088,124.95377,581,405.4210,785,746.375,112,261.54
支付其他与筹资活动有关的现金65,286,505.9855,109,034.3555,113,271.313,703,016.95
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,501,374,630.931,441,690,439.77555,899,017.67277,815,278.49
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额2,102,185,340.492,711,869,531.653,096,100,953.752,897,184,692.93
四、汇率变动对现金及现金等价物的影响7,604,699.4821,480,247.5620,778,229.19-4,082,477.78
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额2,413,310,571.133,127,262,165.793,301,151,607.813,017,760,716.2
加:期初现金及现金等价物余额662,758,780.77662,758,780.77662,758,780.77662,758,780.77
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,076,069,351.93,790,020,946.563,963,910,388.583,680,519,496.97
补充资料:
净利润1,031,371,775.69-621,320,792.4-
资产减值准备78,203,593.39-52,325,556.38-
固定资产和投资性房地产折旧335,372,225.06-161,648,429.8-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧335,372,225.06-161,648,429.8-
无形资产摊销40,688,657.41-22,131,105.12-
长期待摊费用摊销1,856,744.46-823,261.69-
处置固定资产、无形资产和其他长期资产的损失2,543,160.71-454,152.75-
固定资产报废损失1,482,082.61-1,473,962.66-
公允价值变动损失---576,410.55-
财务费用10,947,998.44--3,410,298.36-
投资损失19,363,697.54-15,436,435.93-
递延所得税18,890,395.28-14,655,949.65-
其中:递延所得税资产减少23,682,111.7--4,652,818.62-
递延所得税负债增加-4,791,716.42-19,308,768.27-
存货的减少-9,388,840.76-207,899,716.6-
经营性应收项目的减少-228,543,587.99--316,187,304.98-
经营性应付项目的增加14,458,804.38--93,700,032.26-
其他17,146,016.54-14,577,804.59-
现金的期末余额3,076,069,351.9-3,963,910,388.58-
减:现金的期初余额662,758,780.77-662,758,780.77-
公告日期2024-04-092023-10-282023-08-152023-04-28
审计意见(境内)标准无保留意见
TOP↑